Jared Insel
Cardiovascular Disease · New Britain, CTNPI 1558369561
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.5% of the total across 117 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 15.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $2,149 and has fallen 98.9% since, to $23 in 2025.
Across 117 payments — averaging $20.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$364
- Boehringer Ingelheim$348
- Novartis$289
- Amgen$260
- Pfizer$228
- Amarin Pharma, Inc.$228
- plus $698 from 18 others
What the payments were for
- Food & beverage$2,403100%
- Education$120%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 21 | $364 |
| Boehringer Ingelheim | 12 | $348 |
| Novartis | 11 | $289 |
| Amgen | 12 | $260 |
| Pfizer | 9 | $228 |
| Amarin Pharma, Inc. | 14 | $228 |
| Lundbeck LLC | 6 | $106 |
| Regeneron Healthcare Solutions, Inc. | 5 | $93 |
| E.r. Squibb & Sons, L.L.C. | 5 | $73 |
| Sanofi-aventis U.S. LLC | 4 | $71 |
| AstraZeneca | 3 | $44 |
| Kowa Pharmaceuticals America, Inc. | 3 | $44 |
| Preventice Services, LLC | 1 | $39 |
| Globus Medical | 1 | $39 |
| Actelion Pharmaceuticals US, Inc. | 1 | $25 |
| Vifor Pharma, Inc. | 1 | $25 |
| Alnylam Pharmaceuticals Inc. | 1 | $24 |
| Daiichi Sankyo Inc. | 1 | $20 |
| Astellas Pharma US Inc | 1 | $20 |
| Arbor Pharmaceuticals, Inc. | 1 | $17 |
| Biotronik Inc. | 1 | $17 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $16 |
| AbbVie | 1 | $14 |
| Gilead | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,415 in reported general payments places this provider in the 60th percentile of 415 cardiovascular disease providers in Connecticut.
Other cardiovascular disease in New Britain
- Robert MalkinNew Britain$16K
- Arun AgarwalNew Britain$15K
- James St PierreNew Britain$15K
- Jonathan WinklerNew Britain$10K
- Nihar DesaiNew Haven$1.4M
- Brett NowlanBloomfield$798K
- Jeffery TestaniNew Haven$546K
- Carlos Mena-HurtadoNew Haven$460K
- Stephanie SaucierHartford$243K
- John ForrestNew Haven$164K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.